{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "United States Politics and Government", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Medicare", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Presidential Election of 2016", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Clinton, Hillary Rodham", "name": "persons", "rank": "6", "is_major": "N"}, {"value": "Democratic Party", "name": "organizations", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/01/19/upshot/even-talking-about-reducing-drug-prices-can-reduce-drug-prices.html", "document_type": "article", "byline": {"person": [{"lastname": "FRAKT", "firstname": "Austin", "role": "reported", "organization": "", "rank": 1}], "original": "By AUSTIN FRAKT"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/01/15/upshot/18UP-Healthpay/18UP-Healthpay-thumbWide.jpg", "legacy": {"wide": "images/2016/01/15/upshot/18UP-Healthpay/18UP-Healthpay-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/01/15/upshot/18UP-Healthpay/18UP-Healthpay-articleLarge.jpg", "legacy": {"xlarge": "images/2016/01/15/upshot/18UP-Healthpay/18UP-Healthpay-articleLarge.jpg", "xlargeheight": "394", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 394}, {"url": "images/2016/01/15/upshot/18UP-Healthpay/18UP-Healthpay-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/01/15/upshot/18UP-Healthpay/18UP-Healthpay-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "The Upshot", "word_count": "868", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "A study finds that pharmaceutical companies have cut drug prices in response to political pressure.", "pub_date": "2016-01-19T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "The Upshot", "print_headline": "Even Talking About Drug Prices Can Slow Their Rise", "main": "Even Talking About Reducing Drug Prices Can Reduce Drug Prices", "content_kicker": "The New Health Care"}, "print_page": "3", "snippet": "A study finds that pharmaceutical companies have cut drug prices in response to political pressure.", "_id": "569cd3de38f0d821e003cf06", "slideshow_credits": null, "abstract": "The Upshot; research shows that political talk about reining in drug prices can itself help reduce cost, even if legislation does not emerge; pharmaceutical stocks have declined since Democratic politicians, including presidential hopefuls and Pres Obama, have turned their attention to issue, trend that could encourage firms to lower prices. "}